Binnopharm Group and Vietnamese company VNVC sign a memorandum of cooperation

Binnopharm Group, a leading Russian pharmaceutical company, and VNVC, a Vietnamese company, have signed a memorandum of understanding to develop cooperation in producing and distributing medicinal products in Southeast Asia. The document was signed on May 12, 2025.

A Vietnamese delegation, including representatives from the Vietnamese Ministry of Health and VNVC management, visited the Binnopharm Group Research and Development Centre laboratories, where participants were introduced to cutting-edge drug development technologies.

According to the memorandum, the companies plan to conduct joint research and development of medicinal products for the Vietnamese and Southeast Asian markets. VNVC will also support Binnopharm Group in matters relating to GMP certification, product registration, and international market launch.

Rustem Muratov, CEO, Binnopharm Group: «The signed memorandum creates new opportunities for our organisations. We are committed to sharing our technological solutions and accumulated experience to provide the people of Vietnam and Southeast Asian regions with access to modern medicines».

Ngo Chi Dung, Chairman of the Board of Directors, VNVC: «We see Binnopharm Group as a reliable partner. Our goal is to develop the production of medicines in Vietnam under international standards. We are confident that our cooperation will serve as an example of successful interaction between countries to improve the entire region’s health».

In January 2025, Binnopharm Group opened its representative office in Vietnam to expand its commercial presence in international markets and implement the company’s export growth strategy. This will enable Binnopharm Group to lead in the pharmaceutical market in Russia and other countries where it is present.

Today, Binnopharm Group is the largest exporter of Russian medicinal products to the CIS countries and the Eurasian Economic Union (EAEU). The company’s products are available in 15 countries, and its range includes over 480 medicines.